Next-generation respiratory device that delivers synchronization of flow/temperature/humidity/oxygen percentage, without discomfort, via nasal cannula, for patients with chronic or acute breathing disorders
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Vapotherm (NYSE:VAPO) plus 4809 other startups.